1-2 of 2
Christoph Röllig
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT124: A first-in-clinic phase 1 study of GSK3745417 STING agonist in relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndrome

Pau Montesinos, Haifa Al-Ali, Juan M. Alonso-Dominguez, Madlen Jentzsch, Mojca Jongen-Lavrencic, Maria Paola Martelli, Christoph Röllig, Simona Sica, Riham Iadevaia, Kaitlin Yablonski, Tianli Wang, Zafar Mahmood, Giedre Koenen, Hank Schmidt, Jingsong Yang, Karen Yee
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): CT124.
https://doi.org/10.1158/1538-7445.AM2023-CT124
Published: 14 April 2023
View article titled, Abstract CT124: A first-in-clinic phase 1 study of GSK3745417 STING agonist in relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndrome
Journal Articles

JAM-C Expression as a Biomarker to Predict Outcome of Patients with Acute Myeloid Leukemia—Letter

Malte von Bonin, Katharina Moll, Michael Kramer, Uta Oelschlägel, Martin Wermke, Christoph Röllig, Christian Thiede, Gerhard Ehninger, Alwin Krämer, Carsten Müller-Tidow, Ioannis Mitroulis, Martin Bornhäuser
Journal: Cancer Research
Cancer Res (2018) 78 (21): 6339–6341.
https://doi.org/10.1158/0008-5472.CAN-18-0642
Published: 01 November 2018
View article titled, JAM-C Expression as a Biomarker to Predict Outcome of Patients with Acute Myeloid Leukemia—Letter
Open the PDF for JAM-C Expression as a Biomarker to Predict Outcome of Patients with Acute Myeloid Leukemia—Letter in another window